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Little is known about the effects of current PAH therapies
and receptor tyrosine kinase inhibitors on heart remodel-
ling. We sought to investigate the effects of the multikinase
inhibitors sunitinib (PDGFR-, VEGFR- and KIT-inhibitor)
and sorafenib (raf1/b-, VEGFR-, PDGFR-inhibitor) on
pressure overload induced right ventricular (RV) remodel-
ling. We investigated the effects of the kinase inhibitors on
hemodynamics and remodelling in rats subjected either to
monocrotaline (MCT)-induced PH or to surgical pulmon-
ary artery banding (PAB). MCT rats were treated from day
21 to 35 with either vehicle, sunitinib (1 mg/kg, 5 mg/kg
and 10 mg/kg/day) or sorafenib (10 mg/kg/day). PAB rats
were treated with vehicle, sunitinib (10 mg/kg/day) or sor-
afenib (10 mg/kg/day) from day 7 to 21. RV function and
remodelling were determined using echocardiography,
invasive hemodynamic measurement and histomorphome-
try. Treatment with both sorafenib and sunitinib decreased
right ventricular systolic pressure, pulmonary vascular
remodelling, RV hypertrophy and fibrosis in MCT rats.
This was associated with an improvement of RV function.
Importantly, after PAB, both compounds reversed RV
chamber and cellular hypertrophy, reduced RV interstitial
and perivascular fibrosis, and improved RV function.
We demonstrated that sunitinib and sorafenib reversed
RV remodelling and significantly improved RV function
measured via a range of invasive and non-invasive cardio-
pulmonary endpoints in experimental models of RV
hypertrophy.
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